Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Camptothecin induced topoisomerase I-DNA complexes are targeted and reversed by poly(ADP-ribose)

M. Malanga, O. Cohausz, F. Althaus

Med Sci Monit 2003; 9(1): 38-0 :: ID: 15101

Abstract

Camptothecin (CPT) and its clinically used congeners base their potency as anticancer drugs on the ability to stabilize topoisomerase I-cleaved DNA covalent complexes; such long-lived nucleoprotein complexes constitute a challenge to genomic integrity and cell viability as they can be converted in potentially lethal DNA damage upon collision with replication/transcription machineries [1]. Many DNA structural lesions have been shown to have a similar ‘poisoning’ effect [2]. The observation that PARP inhibitors potentiate the cytotoxicity of CPT in irradiated cells [3] suggests a correlation between poly(ADP-ribose) synthesis and cell’s ability to cope with topoisomerase I-induced DNA damage. Using an in vitro system we investigated whether the steady state level of topoisomerase I-DNA complexes could be modulated by poly(ADP-ribosyl)ation. We observed that both PARP-1 and PARP-2 in their automodified form reduced topoisomerase I-DNA covalent complexes, while they had little or no effect in their native state. The decrease in the number of nucleoprotein complexes occurred even in the presence of CPT and appeared to be specifically dependent on, and proportional to, the amount of PARP-bound poly(ADP-ribose). We found that poly(ADP-ribose) interacts noncovalently with topoisomerase I and identified two binding motifs at critical sites for the enzyme activity. Further experiments revealed that topoisomerase I in covalent complex with its substrate was a preferred target for poly(ADP-ribose). Such specific targeting resulted in a complete reversion of the cleavage complexes, in spite of the stabilizing effect of CPT. Work is in progress to evaluate the occurrence of such poly(ADP-ribose)-mediated repair of topoisomerase I-DNA covalent complexes in living cells. References: 1.Kohn KW, Pommier Y: Annals NY Acad Sci, 2000; 922: 11-26 2.Pourquier P, Waltman JL, Urasaki Y et al: Cancer Res, 2001; 61: 53-58 3.Bowman KJ, Newell DR, Calvert AH, Curtin NJ: Br J Cancer, 2001; 84: 106-112

Keywords: PARP-2, noncovalent interactions, DNA Repair

Add Comment 0 Comments

Editorial

01 April 2025 : Editorial  

Editorial: Rapid Testing for the Avian Influenza A(H5N1) Virus is Urgently Required as Infections in Poultry and Dairy Cows are on the Rise, and so is Transmission to Humans

Dinah V. Parums

DOI: 10.12659/MSM.949109

Med Sci Monit 2025; 31:e949109

0:00

In Press

Clinical Research  

Buccal Acupuncture Reduces the Dose of Sufentanil Needed in Laparoscopic Gynecological Surgery

Med Sci Monit In Press; DOI: 10.12659/MSM.947088  

0:00

Review article  

Global Guidelines and Trends in HPV Vaccination for Cervical Cancer Prevention

Med Sci Monit In Press; DOI: 10.12659/MSM.947173  

0:00

Clinical Research  

Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelome...

Med Sci Monit In Press; DOI: 10.12659/MSM.947873  

0:00

Clinical Research  

Impact of Depression, Fatigue, and Pain on Quality of Life in Slovak Multiple Sclerosis Patients

Med Sci Monit In Press; DOI: 10.12659/MSM.947630  

Most Viewed Current Articles

17 Jan 2024 : Review article   7,932,897

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   702,919

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   29,882

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   23,844

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750